Literature DB >> 8035923

Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia.

O L Lopez1, M R Larumbe, J T Becker, D Rezek, J Rosen, W Klunk, S T DeKosky.   

Abstract

We evaluated the reliability of clinical diagnoses using the recently standardized criteria for the diagnosis of vascular dementia (VaD) developed by the National Institute of Neurological Disorders and Stroke (NINDS) and the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN). Two neurologists and two psychiatrists independently reviewed clinical data abstracted from those of 42 demented subjects participating in a longitudinal study of dementia at the University of Pittsburgh. For each patient we abstracted the clinical data on a standardized form. Each physician diagnosed each case according to the NINDS-AIREN criteria, using both clinical information and MRIs. We calculated the interrater agreement for all two-way combinations of clinicians with kappa statistics, which ranged from 0.46 (moderate agreement) to 0.72 (substantial agreement). The moderate reliability observed in this study may be attributable to patient-, clinician-, or criteria-centered sources of variance.

Entities:  

Mesh:

Year:  1994        PMID: 8035923     DOI: 10.1212/wnl.44.7.1240

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Diagnosis, risk factors, and treatment of vascular dementia.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

Review 2.  Neuroradiological findings in vascular dementia.

Authors:  Ali Guermazi; Yves Miaux; Alex Rovira-Cañellas; Joyce Suhy; Jon Pauls; Ria Lopez; Holly Posner
Journal:  Neuroradiology       Date:  2006-11-18       Impact factor: 2.804

3.  Diagnostic accuracy of Alzheimer's disease: a neuropathological study.

Authors:  O Kosunen; H Soininen; L Paljärvi; O Heinonen; S Talasniemi; P J Riekkinen
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

Review 4.  Classification, diagnosis and treatment of vascular dementia.

Authors:  S Konno; J S Meyer; Y Terayama; G M Margishvili; K F Mortel
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

Review 5.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

6.  Effect of vascular burden as measured by vascular indexes upon vascular dementia: a matched case-control study.

Authors:  Paul Y Takahashi; Casey R Caldwell; Paul V Targonski
Journal:  Clin Interv Aging       Date:  2012-01-08       Impact factor: 4.458

7.  Effect of alcohol and tobacco use on vascular dementia: a matched case control study.

Authors:  Paul Y Takahashi; Casey R Caldwell; Paul V Targonski
Journal:  Vasc Health Risk Manag       Date:  2011-11-15

8.  Clinical and neuroimaging correlates of abnormal short-latency Somatosensory Evoked Potentials in elderly vascular dementia patients: A psychophysiological exploratory study.

Authors:  Iacovos Tsiptsios; Konstantinos N Fountoulakis; Konstantinos Sitzoglou; Anastasia Papanicolaou; Konstantinos Phokas; Fotis Fotiou; George St Kaprinis
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-09-05

9.  Hypertension and small vessel disease: A dangerous association for cognitive impairment over time.

Authors:  Adrià Arboix; Olga Parra
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-29       Impact factor: 3.738

10.  Decreased Levels of Serum IL-34 Associated with Cognitive Impairment in Vascular Dementia.

Authors:  Yang Wang; Wei Lu; Wenjing Ning; Yan Chen; Lingxing Li
Journal:  Biomed Res Int       Date:  2021-05-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.